Remove 2025 Remove Biosimilars Remove Prescription Filling
article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

Formulary Inclusion and Placement of Generics and Biosimilars The NHC supports CMS proposals to improve formulary practices by prioritizing access to generics, biosimilars, and other cost-effective medications in the Medicare Part D program.

article thumbnail

January 2025 Newsletter

Safe Biologics

Small molecule drugs make up over 90% of prescriptions filled in the U.S. A recent survey of doctors who prescribe biosimilars found that only 11% of physicians believe all biosimilars should be deemed interchangeable. Ben Ray Lujn, D-New Mexico, has supported efforts to loosen biosimilar standards.